The full treatment cycle usually runs 12-16 weeks, followed by a break period before potential additional cycles
Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity
Inject on the schedule prescribed, rotate injection sites, and follow aseptic technique
The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
Subcutaneous injection delivers GHK-Cu systemically, which makes more sense for wound healing and skin remodeling protocols
Recheck at six weeks after starting or changing doses